AGIO
AGIOS PHARMACEUTICALS, INC.
AGIOS PHARMACEUTICALS, INC. (AGIO) has 13 SEC Form 4 filings (33 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 10, 2026.
Insiders have net sold $496K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Brian Goff
- Employees:486
- HQ:Cambridge, MA, US
- IPO:2013-07-24
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$496K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$2.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Gheuens SarahFirst in 4 months | Chief Medical Officer | Sale | 4,007 | $151K | Jul 2 | SEC ↗ |
Jones CeciliaFirst filing | Chief Financial Officer | Sale | 5,035 | $146K | Mar 3 | SEC ↗ |
Burns James WilliamFirst filing | Chief Legal Officer | Sale | 4,031 | $117K | Mar 3 | SEC ↗ |
Gheuens SarahFirst filing | Chief Medical Officer | Sale | 2,868 | $83K | Mar 3 | SEC ↗ |
Related companies
AGIOS PHARMACEUTICALS, INC. is in the Healthcare sector.